Vanberra Signal
Free trial

ImmuneWatch

Curated by Signal

Bioinformatics company for the prediction of T-cell specificity and the development of diagnostic tools and therapies

Health Technologyimmunewatch.com

Overview

Bioinformatics company for the prediction of T-cell specificity and the development of diagnostic tools and therapies. It offers AI-powered tools to analyze T-cell receptor sequences which include ImmuneWatch DETECT a bioinformatics tool that annotates epitope specificity on TCR sequences and ImmuneWatch DESIGN that uses machine learning to find epitopes or antigens for vaccine.

Key facts

Founded
2021
Headquarters
Antwerp, Belgium
Stage
Sign up to view
Industry
Health Technology

Business model

5 products and services
Sign up to view

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Acanhi

    Provider of nature-based supplements and natural skincare for dogs

    Health TechnologyMol, Belgium

  • Bridge 2 Health

    Developer of suite of solutions for clinical study and drug discovery

    Health TechnologyLiege, Belgium

  • Aesmedix

    Digital electronic dossier for aesthetic practices

    Health TechnologyBelgium

About ImmuneWatch

What does ImmuneWatch do?

Bioinformatics company for the prediction of T-cell specificity and the development of diagnostic tools and therapies.

Where is ImmuneWatch headquartered?

ImmuneWatch is headquartered in Antwerp, Belgium.

When was ImmuneWatch founded?

ImmuneWatch was founded in 2021.

Which sector is ImmuneWatch in?

ImmuneWatch operates in Health Technology.

Who are ImmuneWatch's competitors?

Companies similar to ImmuneWatch include Acanhi, Bridge 2 Health, and Aesmedix.